Kinnos: Funding, Investors & Team (Sep 2026)
Kinnos is a biotechnology company pioneering color technology to revolutionize how they use disinfectants. The company's first product, Highlight, is a point-of-use additive that greatly improves visibility and end-user compliance of disinfectants. Their goal is to empower people to disinfect surfaces with confidence and to provide society with peace of mind through disinfection they can see.
Kinnos has raised $15.0M across 1 funding round on record, the most recent a Series B of $15.0M announced in May 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kinnos Company Profile and Key Stats
Latest funding round on record: May 2023.
Kinnos Funding Rounds
Kinnos Founders and Leadership Team
Contact details for the Kinnos team: 1 of 1 has an email address on file.
Start 14-day free trial →Kinnos Funding Compared to Other Biotechnology Startups
Kinnos' latest round of $15.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kinnos in Biotechnology and Brooklyn
Companies Similar to Kinnos
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Kinnos Funding FAQs
What does Kinnos do?
Kinnos is a biotechnology company pioneering color technology to revolutionize how they use disinfectants. The company's first product, Highlight, is a point-of-use additive that greatly improves visibility and end-user compliance of disinfectants. Their goal is to empower people to disinfect surfaces with confidence and to provide society with peace of mind through disinfection they can see.
How much funding has Kinnos raised?
Kinnos has raised $15.0M across 1 round on record. The most recent is a Series B of $15.0M announced in May 2023.
When did Kinnos last raise funding?
Kinnos' most recent funding round on record is a Series B of $15.0M, announced in May 2023.
Who founded Kinnos?
FundedIQ lists Kevin Tyan (Founder) at Kinnos.
Where is Kinnos headquartered?
Kinnos is based in Brooklyn, New York, United States.
How many employees does Kinnos have?
Kinnos is in the 11-50 employee band.
How does Kinnos' funding compare to other Biotechnology startups?
Kinnos' latest round of $15.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Kinnos Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kinnos is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.